Prostate Cancer
Prostate cancer is a type of cancer that occurs in the prostate, a small gland that produces seminal fluid in men. It can cause symptoms such as difficulty urinating, blood in urine, and pelvic discomfort.
Prostate Cancer: Enzalutamide Study
We are investigating how Enzalutamide affects molecular changes in men with localized prostate cancer before and after surgery. This study may help us understand its impact on cell growth and gene activity.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you over 18 years old?
- Do you have localized high-risk prostate cancer?
- Are you planning to have surgery to treat your prostate cancer?
- Are you currently taking any medications that could interact with Enzalutamide, like hormones or Finasteride?
- Do you have a partner who is pregnant or capable of becoming pregnant, and are you willing to use a condom during the study?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Enzaluatmide Rowex
Enzalutamid 1 A Pharma
Enzalutamid 1a Pharma
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital Universitario Basurto
UROLOGIA
Barakaldo, Spain
Sponsor: Asociacion Instituto De Investigacion Sanitaria Biobizkaia
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.